Related Experiment Video
Updated: Aug 16, 2026
Osteoarthritis Pain Model Induced by Intra-Articular Injection of Mono-Iodoacetate in Rats
Published on: May 20, 2020
Effects of salicylates on blood changes in mycoplasma arthritis in rats
Abstract:
1. The polyarthritis produced in rats by i.v. inoculation with Mycoplasma arthritidis was made more severe by salicylates.2. The infection increased the erythrocyte sedimentation rate (ESR), serum lysozyme, counts of total white blood corpuscles, polymorphonuclear cells and lymphocytes, haemolytic serum complement (CH 50) and its component C3. Salicylates enhanced the rise in ESR, CH 50 and C3, but suppressed the rise in lymphocytes and even induced a fall.3. Salicylates did not interfere with the development and action of metabolic inhibition antibodies against M. arthritidis, and did not promote the growth of M. arthritidis.4. Rats treated with salicylate during the first infection acquired the same immunity to reinfection as did infected controls.5. Salicylates did not render rats susceptible to M. fermentans which is non-pathogenic to rats, but may be involved in human rheumatoid arthritis.
Insights
Salicylates worsen Mycoplasma arthritidis-induced polyarthritis in rats by increasing inflammation markers. However, salicylates do not hinder immunity development against reinfection.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Mycoplasma arthritidis is a pathogen causing polyarthritis.
- Salicylates are commonly used anti-inflammatory drugs.
Purpose of the Study:
- To investigate the effect of salicylates on Mycoplasma arthritidis-induced polyarthritis in rats.
- To assess the impact of salicylates on immune responses and M. arthritidis infection.
Main Methods:
- Rats were inoculated with Mycoplasma arthritidis to induce polyarthritis.
- Salicylates were administered to assess their effect on disease severity and immune parameters.
- Erythrocyte sedimentation rate (ESR), serum lysozyme, white blood cell counts, and complement levels were measured.
Main Results:
- Salicylates exacerbated polyarthritis and increased inflammatory markers like ESR, haemolytic serum complement (CH 50), and C3.
- Salicylates suppressed lymphocyte counts and enhanced the rise in ESR, CH 50, and C3.
- Salicylates did not impede antibody development against M. arthritidis or affect bacterial growth.
- Salicylate treatment did not compromise immunity to reinfection.
Conclusions:
- Salicylates worsen M. arthritidis-induced arthritis in rats by enhancing inflammation.
- Salicylates do not interfere with protective immunity against M. arthritidis reinfection.
- These findings suggest a complex interaction between salicylates, M. arthritidis infection, and the host immune response.
